By qRT-PCR analysis, we confirmed that the cisplatin-resistant GCC cell lines also upregulated CDKN1A, while P53 was downregulated (2102EP-R) or remained unchanged (NCCIT-R, NT2/D1-R) (Supplementary Figure S3D). Here, TP53 is linked to goblet cell carcinoma.